Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20.9M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
+2.85M
-
Total reported value, excl. options
-
$1.67B
-
Value change
-
+$224M
-
Put/Call ratio
-
0.34
-
Number of buys
-
87
-
Number of sells
-
-62
-
Price
-
$76.96
Significant Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q4 2024
186 filings reported holding PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK as of Q4 2024.
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (1.69M shares), BlackRock, Inc. (1.46M shares), PERCEPTIVE ADVISORS LLC (1.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.21M shares), MORGAN STANLEY (1.16M shares), VANGUARD GROUP INC (1.06M shares), Capital Research Global Investors (994K shares), VR Adviser, LLC (990K shares), JANUS HENDERSON GROUP PLC (930K shares), and STATE STREET CORP (769K shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.